CGTLive’s Weekly Rewind – November 10, 2023

News
Article

Review top news and interview highlights from the week ending November 10, 2023.

CGTLive’s Weekly Rewind – November 10, 2023

CGTLive’s Weekly Rewind – November 10, 2023

Welcome to CGTLive™’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.

1. Adzynma Engineered ERT Therapy Approved for Prophylactic, On-Demand cTTP Treatment

The therapy was previously granted priority review in May 2023.

2. Ben Creelan, MD, on the Potential of Cell Therapy in Non–Small Cell Lung Cancer

The medical oncologist at Moffitt Cancer Center discussed 3 different approaches to cell therapy that could lead to new treatment options in the field.

3. Medeor’s Cell Therapy MDR-101 Allows Patients to Taper off Immunosuppression Following Kidney Transplant

Among 20 patients who received MDR-101, 12 have completed participation in the trial and have not taken their immunosuppression therapy for 2 years.

4. Michael Kelly, PhD, on Continuing Progress in Muscular Dystrophy in 2024

The chief scientific officer of CureDuchenne discussed research he is looking forward to seeing in 2024.

5. Lynch Syndrome Neoantigen Vaccine is Well-Tolerated, Demonstrates Immunogenicity

Microsatellite instability (MSI) tumors are frequently found in people with Lynch syndrome, one of the most common hereditary colorectal cancers.

Recent Videos
Alfred L. Garfall, MD, MS, associate professor of medicine (hematology-oncology) and director, Autologous Hematopoietic Cell Transplantation, Cell Therapy and Transplant Program, Hospital of the University of Pennsylvania; and section chief, Multiple Myeloma, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania,
Reena Sharma, MD, an adult metabolic consultant at Salford Royal Hospital
Nirav Shah, MD, MSHP, associate professor of medicine, at the Medical College of Wisconsin
Bhagirathbhai R. Dholaria, MD, an associate professor of medicine in malignant hematology & stem cell transplantation at Vanderbilt University Medical Center
Reena Sharma, MD, an adult metabolic consultant at Salford Royal Hospital
Mark Hamilton, MD, PhD, a hematology-oncology and bone marrow transplant (BMT) cell therapy fellow at Stanford University
Barry J Byrne, MD, PhD, the chief medical advisor of MDA and a physician-scientist at the University of Florida
Barry J Byrne, MD, PhD, the chief medical advisor of MDA and a physician-scientist at the University of Florida
Sarah Larson, MD, the medical director of the Immune Effector Cell Therapy Program in the Division of Hematology/Oncology at David Geffen School of Medicine at University of California, Los Angeles (UCLA)
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Related Content
© 2025 MJH Life Sciences

All rights reserved.